A detailed history of Paradigm Financial Partners, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Paradigm Financial Partners, LLC holds 3,788 shares of DXCM stock, worth $258,000. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,788
Previous 3,859 1.84%
Holding current value
$258,000
Previous $535,000 19.81%
% of portfolio
0.06%
Previous 0.12%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$110.31 - $140.45 $7,832 - $9,971
-71 Reduced 1.84%
3,788 $429,000
Q1 2024

May 15, 2024

BUY
$114.22 - $140.1 $7,195 - $8,826
63 Added 1.66%
3,859 $535,000
Q4 2023

Feb 05, 2024

BUY
$75.49 - $124.16 $4,000 - $6,580
53 Added 1.42%
3,796 $471,000
Q3 2023

Oct 12, 2023

BUY
$86.06 - $137.93 $23,408 - $37,516
272 Added 7.84%
3,743 $349,000
Q2 2023

Jul 13, 2023

SELL
$112.47 - $130.98 $1,349 - $1,571
-12 Reduced 0.34%
3,471 $446,000
Q4 2022

Jan 27, 2023

SELL
$84.98 - $122.67 $38,071 - $54,956
-448 Reduced 11.4%
3,483 $0
Q3 2022

Nov 09, 2022

SELL
$76.35 - $94.18 $5,955 - $7,346
-78 Reduced 1.95%
3,931 $374,000
Q2 2022

Jul 27, 2022

BUY
$67.99 - $132.89 $203,766 - $398,271
2,997 Added 296.15%
4,009 $328,000
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $7,526 - $10,416
80 Added 8.58%
1,012 $516,000
Q4 2021

Feb 18, 2022

SELL
$129.87 - $162.82 $747,142 - $936,703
-5,753 Reduced 86.06%
932 $500,000
Q4 2021

Feb 10, 2022

BUY
$129.87 - $162.82 $746,362 - $935,726
5,747 Added 612.69%
6,685 $897,000
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $9,070 - $12,170
85 Added 9.96%
938 $506,000
Q2 2021

Aug 12, 2021

BUY
$80.99 - $107.93 $8,018 - $10,685
99 Added 13.13%
853 $364,000
Q1 2021

May 14, 2021

BUY
$84.79 - $104.74 $12,888 - $15,920
152 Added 25.25%
754 $271,000
Q4 2020

Feb 12, 2021

BUY
$78.0 - $104.5 $46,956 - $62,909
602 New
602 $233,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Paradigm Financial Partners, LLC Portfolio

Follow Paradigm Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Financial Partners, LLC with notifications on news.